Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 164

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 19
Chunk 164
---
4.  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

As
of December 31, 2024 and 2023, the Company had net operating losses carry forward (including temporary taxable difference of bad debt
expense) of approximately $ 3.7 3.2 0.7 0.5

Uncertain
tax positions

The
Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical
merits, and measure the unrecognized benefits associated with the tax positions. As of December 31, 2024 and 2023, the Company did not
have any significant unrecognized uncertain tax positions. The Company did not incur interest and penalties tax for the years ended December
31, 2024, 2023 and 2022.

Taxes
payable consist of the following:

Schedule
of taxes payable

                            December 31, 2024                   December 31, 2023               
 ────────────────────────────────────────────────────────────────────────────────────────────────
  GST taxes payable         $                      260,243      $                      192,956  
  Income taxes payable                               2,801                              15,699  
  Totals                    $                      263,044      $                      208,655  

EUDA
HEALTH HOLDINGS LIMITED AND SUBSIDIARIES

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

(In
U. S. dollars, unless stated otherwise)

Note
18 - Concentrations risks

(a)
Major customers

For
the years ended December 31, 2024, no customer accounted for more than 10.0 11.3 10

As
of December 31, 2024, two customers accounted for 19.0%
and 15.0%
of the Company’s total balance of accounts receivable, respectively. As of December 31, 2023, three customers accounted for 23.9%, 11.9%,
and 10.6%
of the Company’s total balance of accounts receivable, respectively.

(b)
Major vendors

For
the years ended December 31, 2024, 2023 and 2022, no vendor accounted for 10

As
of December 31, 2024, two vendor accounted for 79.9 10.7 10

(c)
Credit risk

Financial
instruments